Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_pagePreview
Challenges Working with Terminally-Ill Patients in an International Rare Disease Study

Pharm-Olam is a clinical research organization (CRO) that has vast experience in rare diseases. To date, we have completed...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Natural History - Case Study: Ultra Rare Disease in Subjects Aged 3 Years and Younger

Pharm-Olam is a clinical research organization (CRO) with global reach and deep expertise in rare disease research. Our...


(3 minute read)

Tags: Rare & Orphan Disease

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover